Active Not RecruitingNCT05306184

Prospective Assessment of Cost-effectiveness and Side-effects of Depressive Patients Treated With ECT or TCA

This study is active but not recruiting. It focuses on depression and currently lists study information in the Netherlands.

Depression, Eating disordersObservationalOver 18 Years

The study in practice

Understand this study

Listed age limits: from 18 years.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateStarted: January 1, 2022

Recruitment status: Active Not Recruiting
Enrollment listed in the registry: 220
Sponsor: Radboud University Medical Center
Sponsor type: Hospital / academic medical center
Study type: Observational
Intervention type: PROCEDURE
Study phase: Not clearly listed
Locations: Netherlands
Age range: Over 18 Years
Official registry ID: NCT05306184
Official title: Prospective Assessment of Cost-effectiveness and Side-effects of Depressive Patients Treated With ECT or TCA

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Study ID: NCT05306184. We help you review the study, but cannot decide medical eligibility.

Not recruiting

Amsterdam, Netherlands · Nijmegen, Netherlands

Compensation and expense reimbursement have not been verified for this summary.

FAQ

Who is behind this study?

The study sponsor is Radboud University Medical Center, a hospital or academic medical center.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.